Abstract
Purpose of Review
Motives, or reasons, for cannabis use are salient proximal indicators of cannabis use. The purpose of the present review is to provide an overview of recent research examining motives for cannabis use and a discussion of implications for research, practice, and policy.
Recent Findings
We identified recent studies for this review through searches in PsycINFO, PubMed/Medline, and CINAHL using a variety of terms for “cannabis” and “motives” to capture a broad literature since 2017. The majority of studies examined cannabis motives derived from the motivational model, specifically coping, enhancement/enjoyment, expansion, social, and conformity, with the largest portion of these focused on coping motives. A similarly large body of research focused on medical motives, or using cannabis for medical or “health” reasons. A concerning feature of some medical/health related reasons for using cannabis is their overlap with coping-related reasons and the development of subsequent use-related problems and cannabis use disorder (CUD).
Summary
Understanding why individuals use cannabis is critical to determining how it will be used and whether problems develop related to use. Future research is necessary to distinguish between medical/health motives and coping motives, which should inform policy and clinical practice.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Cannabis is among the most commonly used substances in the U.S., and rates of use have steadily increased over the past decade [1, 2]. As of 2022, among young adults aged 19–30, past month prevalence of cannabis use was the same for men and women, closing a decades-long gap in which men had demonstrated a higher prevalence of past-month use than women. Increasing prevalence of past month cannabis use was also observed in adults aged 35–50, although rates of use in men remained higher relative to women. Past month rates of use have also increased across Black, Hispanic, and non-Hispanic white young adults. Although these groups appeared to use cannabis at a similar rate in 2022, past month use prevalence among Hispanic adults almost doubled from 2021. Daily or near daily use is also increasing and is especially prevalent among young adults (~ 11%) with the highest prevalence among “emerging adults” age 18–24 (~ 18%). This is of particular concern given that this level of frequency is associated with more cannabis-related problems and an increased risk of cannabis use disorder (CUD) [3]. On a positive note, adolescent use has largely remained stable, even in the wake of broadening medical and recreational cannabis legalization and decriminalization [1]. An important factor to consider in relation to increased prevalence rates is the reasons why individuals are using cannabis.
The motivational model of substance use, initially proposed to describe reasons for alcohol use, states substances are used to achieve a certain affect [4,5,6]. The source of the affect change may be internal or external, and the valence may be negatively or positively reinforcing. Thus, reasons someone might use a substance are to cope with a negative mood (internal, negatively reinforcing), to enhance a positive mood (internal, positively reinforcing), to conform with the expectations of peers (external, negatively reinforcing), and for social facilitation (external, positively reinforcing) [4, 5]. Pharmacological differences across substances have important implications for the specific reasons someone might use a particular substance. Thus, in addition to these original four motives, expansion motives (to expand awareness) is a validated subscale which significantly predicted cannabis but not alcohol use [7]. These five motives are typically assessed using the Marijuana Motives Measure (MMM) which has shown significant positive associations with more frequent cannabis use and more use-related problems, including impacts on motivation and productivity as well as cannabis dependence and dependence of other substances such as alcohol [7]. In a recent meta-analytic review, use for coping, enhancement, social, and expansion reasons were associated with more frequent cannabis use, and all five motives were associated with greater cannabis use-related problems, most commonly assessed by the Marijuana Problems Scale [8], across a range of adolescent, undergraduate, community, and veteran samples [9]. The Comprehensive Marijuana Motives Questionnaire (CMMQ) includes assessment of these five motives as well and has also validated several other subscales of motives that, while likely not exclusive to cannabis, provide an extensive list of reasons someone may use cannabis, including for celebration, boredom, or sleep; because it is low risk; or simply because it is available [10]. While both the MMM and CMMQ provide relatively simple assessments of cannabis use motives, neither include items related to medical use. With the broadening legalization of cannabis for medical use at the state level in the U.S. and federally in Canada and other countries, as well as a growing body of research on the therapeutic uses of cannabis for certain medical conditions, use for medical or “health” related reasons is also highly relevant [11].
Motives, especially to cope with negative affect, are robust proximal indicators of use and related problems [6, 9]. That is, having more and varied reasons for using is a strong marker of a higher frequency of use, and some motives in particular, such as coping with negative affect, point to more problematic use [12]. Thus, better understanding why an individual uses cannabis has clear implications for prevention and intervention approaches, and, in the case of medical cannabis, the treatment of medical and other mental health conditions and policy related to medical cannabis. The aim of this narrative review is to provide a summary of recent research on cannabis use motives. We searched PsycINFO, PubMed/Medline, and CINAHL databases using search terms that included variations of “cannabis” and “marijuana,” as well as variations of “reasons” and “motives” to capture as broad a literature as possible between 2017 and 2023. We present our findings based on the relative density of the research over the past five years on different motives or reasons for use stemming from the motivational model, followed by medical and health related reasons. Much of the research on reasons for cannabis use has utilized measures derived, at least in part, from the motivational model [7, 10]; therefore, aside from medical reasons, our findings are organized by motives defined by the motivational model. This review focuses on the role of motives on cannabis use and problems and on characteristics of individuals endorsing certain types of motives. See Table 1 for a visual summary. We conclude with a brief discussion on implications for practice and future research.
Research on Coping Motives
Relative to other cannabis use motives, coping motives, or using to avoid or escape adverse psychological states such as negative or unpleasant emotions, have been consistently linked to elevated use and related problems [5, 7, 9]. Multiple studies have identified coping motives as a significant mediator of the relation between depressive and anxiety symptoms (including social anxiety) and cannabis use, consequences, and CUD symptoms [13,14,15,16,17]. One study demonstrated elevated depressive and anxiety symptoms were associated with greater risk of consequences and CUD via greater coping motives leading to increased use [15]. Emotion dysregulation, perceived distress tolerance, and childhood traumatic experiences have also demonstrated indirect effects via coping motives on cannabis use and problems, as well as craving and withdrawal [18,19,20,21]. To highlight the robustness of these relations, these findings are not unique to cannabis and have been observed for alcohol coping motives, use, and problems as well, signaling the importance of assessing for motives related to coping across substances [13, 17, 19].
Coping Motives in Minoritized Groups
Recent research on coping motives highlights the role of belonging to a minoritized group and minority stress on coping-related reasons for cannabis use (see Table 1). Recent research on coping-motivated cannabis use has focused most frequently on Black/African Americans and sexual minority women and gender diverse people. This is perhaps, in part, a reflection of the larger sociopolitical climate. For example, there is evidence to suggest that significant psychological distress, particularly in 2020, a year of considerable turmoil, was associated with increased cannabis use frequency in U.S. adults [22].
The minority stress theory proposes individuals belonging to minoritized racial, ethnic, sexual, and gender identity groups have an elevated risk for substance use and use disorders because of the stress related to belonging to a minoritized group in the U.S., on top of general stressors experienced, and that this elevated risk stems from the depletion or lack of other, substance-free coping resources [23, 24]. Microaggressions and other forms of perceived racial discrimination, subtle or blatant, are stressors unique to minoritized groups, and have demonstrated associations with elevated negative affect and subsequent coping motives predicting cannabis use and related problems [25, 26]. Depressive symptomatology, one form of negative affect, is strongly associated with coping motivated cannabis use and past year use frequency among Black/African American adolescents and emerging adults [14]. A recent study of Black undergraduate students attending a predominantly white institution found that distressed coping motives fully mediated the relation between subtle perceived racial discrimination (e.g., microaggressions) and cannabis use [26]. Additionally, American Indian youth endorse greater cannabis coping motives relative to their white peers, which may also be associated with experiences of discrimination, though more research is needed to clarify this relationship [27]. Considerably more research is also necessary to assess the prevalence of cannabis use motives across racial and ethnic minority groups, and to determine what internal and external factors predict motives for use and how these motives influence use patterns and related problems to better inform and tailor prevention and treatment interventions [28].
Sexual minority (SM) (e.g., lesbian, gay, bisexual) individuals have an elevated risk for developing CUD [29,30,31]. Recent research, predominantly conducted with SM women, has also found associations between minoritized group status, stigma, cannabis coping motives, and cannabis outcomes. An ecological momentary assessment (EMA) study of sexual minority women and gender diverse people found enacted stigma increased the likelihood of cannabis use among those who endorsed greater coping motives and that higher cannabis consumption and intoxication occurred on days when coping motives were reported [32, 33]. Enacted stigma also predicted an increase in cannabis coping motives and subsequent problematic use over time among Bi + emerging adults assigned female at birth [34]. In a study of Black undergraduate students at a predominantly white institution, those who identified as a SM reported greater cannabis use frequency and consequences relative to straight/heterosexual peers, and coping motives mediated the association between SM status and cannabis use frequency [35]. Further, cannabis disparities for SM individuals widened during the COVID-19 pandemic. Greater cannabis use frequency, consequences, and coping motives were observed among SM individuals during the pandemic relative to non-SM individuals independent of pre-pandemic levels, and coping motives predicted cannabis use and consequences in SM individuals but not in non-SM individuals [36].
Altogether, coping motives for cannabis use remain a robust indicator of cannabis use and related problems. It will be critical for prevention and treatment intervention efforts to target coping motives, alternatively teaching skills, providing more substance-free resources to help manage negative affect, and addressing mental health symptoms early to help prevent the onset of use [37]. Understanding the source of negative affect (e.g., perceived racial discrimination), especially in individuals identifying as belonging to minoritized groups, and its role in coping motivated use will be crucial to developing efficacious targeted interventions.
Research on Enhancement, Social, Expansion, and Conformity Motives
Enhancement/Enjoyment
People are often motivated to use substances such as cannabis as a method of enhancing positive experiences that may arise as a result of intoxication [7]. Perhaps unsurprisingly, those with a greater number of substance-using peers are more likely to report enhancement motives, and enhancement motives are endorsed more often on the weekend, as well as on days when people report greater use [14, 33, 38]. Importantly, only weekend enhancement motives were associated with cannabis-related problems, suggesting that a subset of people may seek enjoyment from cannabis use at the expense of other, possibly more important or meaningful, activities on the weekend. While this reason for use is common, prevalence of enhancement motives may vary according to sociocultural factors. Similar to coping motivated use among Black/African American sexual minority individuals, enhancement motives were also more likely in this group relative to heterosexual/straight individuals; however, enhancement motivated use was not associated with greater cannabis use frequency, highlighting some differential patterns of use related to different motives [35].
Broadly, enhancement/enjoyment motives are associated with greater cannabis use and adverse health outcomes [32, 39,40,41]. Among a Canadian cohort of community adults, greater cannabis use was associated with greater endorsement of enhancement motives, regardless of sociodemographic factors. Interestingly, enhancement motives have been found to predict more problematic use according to the Cannabis Use Disorders Identification Test–Revised (CUDIT-R), but not DSM-5 criteria, suggesting that problems associated with greater enhancement motivated use are subthreshold of a use disorder [40]. This could signal a point for implementation of early intervention. As a mediator between mental health problems and cannabis use and related problems, the role enhancement motives plays is unclear (see Table 1). Some research indicates there is a negative relationship between depressive symptoms and enhancement motives, with one study demonstrating that this, in turn, was associated with lower cannabis use and related harms [42, 43]. While this may suggest a potential protective effect, another study found positive associations, suggesting that those with depression may use cannabis to experience pleasure, resulting in greater use related problems [16]. Clearly, this area warrants considerably more research, with one potential focus to discern the role of enhancement motives on cannabis use and problems trajectories and how it may be leveraged in the design of prevention and intervention programs.
Social Motives
Similar to enhancement motives, social motives typically stem from an individual’s desire to have a positive experience [7]. Key hallmarks of social use motives include the desire to “celebrate a special occasion with friends” or because it “makes social gatherings more fun.” Relative to coping and enhancement motives, social motives have been inconsistently linked to cannabis use frequency and harms, with some studies finding positive associations with cannabis outcomes and others finding no relation [6, 14, 16, 44, 45]. Similar to coping and enhancement motives, evidence indicates social motives are common among minoritized groups. Among sexual minority women and gender diverse individuals, endorsing social motives was associated with more same-day cannabis use and consequences, and these relationships were moderated by typical use frequency [33]. Alternatively, while social motives were among the most frequently endorsed motives in a sample of Black/African American adolescents and emerging adults after enhancement motives, they were not associated with more frequent use [14]. More research is necessary to better understand social motives for cannabis use and the circumstances under which they may predict cannabis use related harms.
Expansion Motives
While the previously discussed motives originated from alcohol research, expansion was introduced as an explanation for cannabis and other psychedelic type substances [7]. Expansion represents a motivation for seeking expanded experiential awareness, characterized by items such as, “I use cannabis so I can know myself better” or “…it helps me be more creative and original.” Although expansion is less commonly reported compared to other motives, it may be more frequently endorsed by men compared to women, as well as sexual minority individuals relative to straight individuals [35, 38, 39, 46]. Evidence from a meta-analysis, a daily diary study, and a longitudinal study indicate that expansion motives are consistently associated with cannabis use frequency, but not cannabis related problems [9, 46, 47]. However, among college students reporting past month cannabis and alcohol use, stress, anxiety, and depression were positively related to cannabis use quantity and negative consequences via expansion motives [42]. Additionally, research has found expansion motives to moderate the relationship between stress and anxiety, such that the association between stress and anxiety grew stronger as expansion motives increased, suggesting that use for expansion reasons may exacerbate negative affective symptoms [48]. In general, expansion motives appear to be positively related to cannabis use frequency, however, its contribution to cannabis-related harms is less clear or consistent, and, in light of growing evidence that expansion motives may be implicated in developing negative affective symptoms, further research is necessary.
Conformity Motives
Conformity motives for cannabis include using “because my friends pressure me to use marijuana,” “to be liked,” and “so I won’t feel left out” [7]. Similar to expansion motives, significantly less research has focused on conformity motives. This may be due to inconsistent findings from earlier studies either failing to demonstrate an association between conformity motives and cannabis use frequency or finding a negative association [49,50,51]. Further, a recent meta-analytic review of 48 studies found significant positive correlations between cannabis use frequency and all motives except for conformity [9]. Among specific population groups, a negative association is seen for conformity motives. For example, in a sample of Black/African American adolescents conformity motives predicted less past-12 month cannabis use [14]. In contrast, one study involving predominantly white female college students found conformity motives to be positively predictive of scores on the CUDIT-R screening tool [40].
Despite the majority of findings from recent studies, conformity motives may play an important role in the context of mental health concerns, particularly anxiety. Among college students who use cannabis, conformity motives were found to significantly moderate the association between stress and anxiety, and in the opposite direction between anxiety and stress, thus suggesting a bi-directional relationship in which the strength of this relationship is increased when individuals’ use is motivated by a desire mitigate external pressure to use [48]. Perhaps unsurprisingly, conformity motives have also been found to moderate the relationship between social anxiety and behavioral willingness to use cannabis [52]. Although research on conformity motives as a moderator of mental health concerns is sparse, these recent findings suggest that individuals with elevated stress or anxiety, specifically social anxiety, may benefit from interventions targeting conformity motives as well as coping motives as highlighted previously.
Research on Medical Use Motives
There is sufficient research evidence to support the use of medical cannabis (typically low concentration of Δ9-tetrahydrocannabinol, THC; higher in concentration of cannabidiol, CBD) for symptom management of certain medical conditions, including chronic pain and multiple sclerosis (MS), and often successfully used for its anti-emetic properties in cancer patients undergoing chemotherapy [11, 53, 54]. However, in states that have legalized the medical use of cannabis, there are several qualifying conditions (varying by state) for which a physician may verify the use of medical cannabis that are not sufficiently supported by research. In some states, it is up to the physician’s discretion as to what medical conditions are “qualifying” and may not be listed under the state’s law [53].
Research on motives for medical cannabis (MC) use has increased rapidly in recent years. The most frequently cited reasons for MC use were to manage chronic pain and/or other chronic conditions such as glaucoma, cancer, and HIV/AIDS, followed by to help with sleep [15, 55,56,57,58,59,60,61,62,63,64]. However, not all cited reasons are for medical conditions or supported by evidence-based research. For example, there is evidence indicating that cannabis may actually disrupt circadian rhythms, thereby negatively impacting sleep [11, 53, 65]. Similarly, a large study of individuals across the U.S. and Canada (N = 27,169) assessed self-reported physical health reasons for medical cannabis use, finding headaches/migraines, appetite, and nausea/vomiting, in addition to pain management and sleep, to be the most common, and self-reported mental health reasons, finding anxiety, depression, and posttraumatic stress disorder (PTSD)/trauma, as well as managing other drug or alcohol use and psychosis, to be the most common [58]. Similar to pain management, MC seems to be useful in improving appetite and alleviating nausea/vomiting as it is indicated for individuals with wasting disease as a result of HIV/AIDS and as an anti-emetic option for individuals undergoing chemotherapy [11]. However, there is limited or insufficient evidence to support cannabis use for mental health symptoms, which can include appetite or weight loss, or psychiatric disorders [54, 66]. Alternatively, some recent research suggests MC use may be protective against heavier alcohol use, and possibly other drug use and use disorders [67,68,69]. Overall, although chronic pain is the most commonly cited reason for MC use and has the most evidence-based support, many people report using cannabis for health-related reasons that are not supported by research.
Medical Motives Across Age Groups
Approximately 25% of adolescents and adults (18 +) across the U.S. and Canada who use cannabis self-report ever using cannabis for medical reasons [58, 70]. As noted in Table 1, although some research has observed a higher prevalence of use for medical reasons in young adults (26–35 years) [58], other evidence suggests that adults who use for medical reasons were more likely to be over age 45 [56, 71]. Notably, older adult populations (51 +) were more likely to report MC use, specifically for chronic pain and other chronic or somatic conditions [56, 71], whereas adolescents (14–17) and young adults (18–30) report MC use when bored or for health reasons not necessarily related to a medical condition (e.g., to improve sleep, energy, appetite) [39, 56, 72], suggesting there could be age-related factors moderating cannabis use motives. There is also some incongruent evidence by sex/gender. In some cases, men were more likely to self-report cannabis use for medical reasons, whereas in others, individuals who use for medical reasons, or both medical and recreational, were more likely to be women [58, 63, 71, 73]. It is not entirely clear why these incongruencies exist. A number of factors could explain these disparate findings including sampling and data collection procedures and/or how MC use was defined by researchers. There could also be differing perceptions as to what MC use is as a function of sex/gender. For example, men and women tended to report different symptoms or conditions for which they use MC, with men reporting use for cancer, bipolar disorder, and problems related to alcohol or other drug use, and women reporting use for sleep, headaches/migraines, and anxiety [58]. Thus, depending on the sampling procedures and the definition of MC used in a study, incongruencies could arise in terms of who is more or less likely to endorse medical reasons for cannabis use or use of MC.
People reporting MC use appear to meet CUD criteria at similar or slightly higher rates relative to those in the broader population of people who use cannabis recreationally [74], and cannabis problems are positively associated with a number of non-medical use motives among MC patients, such as use for enjoyment, coping reasons, boredom, and social anxiety [75]. The effect of medical motives on cannabis use and problems appears to be largely dependent on the types of endorsed medical or health related motives for cannabis use and age-related factors. A recent meta-analysis of MC studies observed more problematic use of medicinal cannabis in younger populations (18–29) and a greater likelihood of CUD in individuals with worse mental health (e.g., depression, posttraumatic stress disorder, psychotic disorders, and other SUDs) [74]. Regarding age-related factors, younger MC patients (18–30) have reported higher quantities of use and higher rates of problematic use relative to middle-age (31–50) and older patients (51 +) [56]. Among 9th-12th graders in Ontario, Canada, relative to non-medical use, MC use was associated with several risk factors including more frequent cannabis use, greater risk for cannabis dependence, a higher likelihood of using tobacco and recreational use of other drugs, and a lower likelihood of reporting good health and adequate sleep [70]. In a sample of French high school students, “health” motives (e.g., to improve sleep, form, energy, appetite, health) were a strong predictor of use frequency and problematic use, and in a sample of French college/university students, they were the strongest predictor of CUD relative to all other motives (e.g., coping, enhancement) [39, 72]. Indeed, self-medicating with cannabis among young adults appears to be widespread and for reasons that are indicative of more substantial problems [76].
In addition to being associated with use patterns and problems, health-related reasons may also drive selection of cannabis products. For example, endorsement of use motives significantly differed by oral cannabis product use and individuals endorsing medical cannabis use report greater use of non-combustible cannabis products [77, 78]. Furthermore, use motives may be related to selection of products based on cannabinoid content. THC and CBD have different pharmacological and subjective effects; people rate products containing CBD as being more therapeutic than THC only products [79].
Across all age groups, perceptions of medical reasons for cannabis use seem to be quite broad and do not necessarily consider the quality or availability of evidence for the efficacy of MC for medical conditions and health-related symptoms. Implications for use patterns and the risk of developing CUD are evident. More research on conditions that MC can be considered an evidence-based treatment for is critical for defining “qualifying” conditions as well as for providing clear education and guidance for patients and providers to prevent use that could result in problems, e.g., CUD. Further, terminology should be made clear regarding “use of medical cannabis” prescribed by a physician for evidence-supported conditions, vs. “use of cannabis for medical/health reasons,” the latter of which seems more subject to individual judgment.
Conclusions and Implications for Practice, Policy, and Future Research
Motives are robust proximal indicators of cannabis use and, in some cases, related problems (e.g., CUD). Recent research on cannabis use motives highlights an important distinction to be made between use for evidence-based medical conditions (e.g., chronic pain management) and use for “health reasons,” either physical or psychological (e.g., depression, anxiety). Indeed, coping motives comes from the motivational model and is characterized by use to manage adverse psychological states [7]. It is possible that individuals who use to manage physical symptoms may be likely to also use to manage psychological symptoms; however, limited research on this topic exists. Research to distinguish domains of motives to manage adverse experiences is urgently needed. Further, this distinction may be especially important for adolescents and young adults who are more likely to report use for “health reasons,” given that these have stronger associations with increased cannabis-related problems. However, it is important to acknowledge the cannabis use motives literature for adults (broadly defined as age 25 +) is limited compared to that of younger populations. With the ever-broadening legalization of medical and recreational cannabis, prevention and early interventions may benefit from an informed and collaborative discussion of the reasons youth are using cannabis and the difference between use for evidence-based medical conditions and use for “health reasons” and self-medication.
Although medical cannabis plays a critical role in the symptom management of certain medical conditions, decreasing perceptions of risk and inconsistent medical cannabis policies by state in the U.S. may contribute to conflating use for evidence-based medical conditions with use for any physical or mental health-related reasons despite a lack of sufficient evidence [1, 11, 53, 66]. In terms of medical cannabis related policy, while a federal level policy could provide the most clarity and consistency, at minimum, states should work collaboratively to design policies that are consistent with available medical research and align with policies and procedures in other states, especially on the designation of “qualifying” conditions. Consistency across the U.S., and globally, lends itself to clearer messaging regarding the use of medical cannabis. Additionally, healthcare providers and healthcare systems can also play an important role in reducing harms associated with use of cannabis for medical and non-medical reasons by following the Screening, Brief Intervention, and Referral to Treatment (SBIRT) stepped-care approach [80]. Incorporating a rapid assessment of reasons for cannabis use within the screening or brief intervention portion can provide some insight into the level of risk and the focus of the brief intervention or referral to treatment required to minimize risk.
Further, to maximize the potential benefits of the therapeutic use of medical cannabis and minimize harms associated with “self-medicating” or “off-label” use, it is necessary to determine how different reasons for use influence how an individual uses cannabis, beyond use frequency alone, and whether this manner of use predicts problems. One avenue may be examining the selection of cannabis products (e.g., combustible, edibles, oils/concentrates) and reasons for use. Cannabis products vary considerably in their cannabinoid composition (e.g., THC and CBD) and reasons for use may not only drive use frequency/quantity, but also selection of products which in turn could have an important impact on cannabis-related harm. As we are familiar with only one study that specifically examines perceptions of cannabis by cannabinoid content [79], this is an important aspect for future study, which in turn will be critical to informing intervention and policy.
In addition, while recent research on cannabis use motives has extended somewhat to older age groups, the predominant focus of this research remains within younger demographics. Research on cannabis use motives in middle-age (31–50) and older adult (51 +) populations has, understandably, primarily focused on medical-related motives; however, motives for use do not occur in a vacuum and often individuals use for various intersecting reasons that change over time [50]. With significant increases in past month cannabis use among middle-age and older adults, additional work is needed to understand the course of cannabis motives in relation to use beyond young adulthood [81]. Further, qualitative research among older adults suggests there may be an immediate need for educational resources on this topic for this particular age group and physicians treating them [59, 62]. Finally, recent research also highlights the need for continued exploration on how intersecting identities and experiences related to age, sex and gender, sexual minority status, and race and ethnicity are associated with motives for cannabis use and cannabis use outcomes.
Despite a relatively extensive literature on cannabis use motives, rapidly changing policies and perspectives on cannabis use are raising important questions regarding why and how people use cannabis, particularly in regard to its medical use (see also the discussion in Dawson et al. [74]). Recent research demonstrates that this can have significant impacts on cannabis and other health related outcomes and that important age, sex/gender, sexual minority, and racial/ethnic background related differences exist. Clarity in how motives develop and change over time across demographic groups is also critical for targeted prevention and treatment intervention efforts. Continued research is necessary to better inform policy and clinical practice.
References
Patrick ME, Miech RA, Johnston LD, O’Malley PM. Monitoring the Future Panel Study annual report: National data on substance use among adults ages 19 to 60, 1976–2022. Ann Arbor, MI: Institute for Social Research, University of Michigan. 2023;192.
Center for Behavioral Health Statistics and Quality. Results from the 2021 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration. 2022.
Robinson T, Ali MU, Easterbrook B, Coronado-Montoya S, Daldegan-Bueno D, Hall W, et al. Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug Alcohol Depend. 2022;238:109582.
Cox WM, Klinger E. A motivational model of alcohol use. J Abnorm Psychol. 1988.
Cooper M. Motivations for alcohol use among adolescents: Development and validation of a four-factor model. Psychol Assess. 1994;6:117–28.
Cooper ML, Kuntsche E, Levitt A, Barber LL, Wolf S. Motivational models of substance use: A review of theory and research on motives for using alcohol, marijuana, and tobacco. Oxf Handb Subst Use Disord. 2016;1–117.
Simons J, Correia CJ, Carey KB, Borsari BE. Validating a five-factor marijuana motives measure: Relations with use, problems, and alcohol, motives. J Couns Psychol. 1998;45:265–73.
Stephens RS, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 2000;68:898–908.
Bresin K, Mekawi Y. Do marijuana use motives matter? Meta-analytic associations with marijuana use frequency and problems. Addict Behav. 2019;99:106102.
Lee CM, Neighbors C, Hendershot CS, Grossbard JR. Development and Preliminary Validation of a Comprehensive Marijuana Motives Questionnaire. J Stud Alcohol Drugs. 2009;70:279–87.
Amin MR, Ali DW. Pharmacology of medical cannabis. In: Bukiya AN, editor. Recent Adv Cannabinoid Physiol Pathol. Cham: Springer International Publishing; 2019. p. 151–65.
Espinosa A, Ruglass LM, Conway FN, Jackson KM, White HR. Motives, frequency, and consequences of cannabis use among college students. J Drug Issues. 2022;00220426221093608.
Bravo AJ, Pearson MR, Baumgardner SF. The relationship between negative affect and alcohol and marijuana use outcomes among dual users. Subst Use Misuse. 2020;55:658–65.
King VL, Mrug S, Windle M. Predictors of motives for marijuana use in African American adolescents and emerging adults. J Ethn Subst Abuse. 2022;21:3–21.
Livingston NR, Hetelekides E, Bravo AJ, Looby A. Negative affect regulation and marijuana use in college students: Evaluating the mediating roles of coping and sleep motives. J Psychoactive Drugs. 2023;55:203–12.
Scarfe ML, Muir C, Rowa K, Balodis I, MacKillop J. Getting high or getting by? An examination of cannabis motives, cannabis misuse, and concurrent psychopathology in a sample of general community adults. Subst Abuse Res Treat. 2022;16:11782218221119070.
Villarosa-Hurlocker MC, Bravo AJ, Pearson MR. The relationship between social anxiety and alcohol and marijuana use outcomes among concurrent users: A motivational model of substance use. Alcohol Clin Exp Res. 2019;43:732–40.
Brammer WA, Conn BM, Iverson E, Lankenau SE, Dodson C, Wong CF. Coping motives mediate the association of trauma history with problematic cannabis use in young adult medical cannabis patients and non-patient cannabis users. Subst Use Misuse. 2022;57:684–97.
Lucke HR, Harbke CR, Mathes EW, Hammersley JJ. Higher emotion dysregulation and coping motives in alcoholand marijuana users. Subst Use Misuse. 2021;56:950–61.
Meshesha LZ, Abrantes AM, Anderson BJ, Blevins CE, Caviness CM, Stein MD. Marijuana use motives mediate the association between experiences of childhood abuse and marijuana use outcomes among emerging adults. Addict Behav. 2019;93:166–72.
Peraza N, Smit T, Garey L, Manning K, Buckner JD, Zvolensky MJ. Distress tolerance and cessation-related cannabis processes: The role of cannabis use coping motives. Addict Behav. 2019;90:164–70.
Choi NG, Marti CN, DiNitto DM, Choi BY. Psychological distress, cannabis use frequency, and cannabis use disorder among US adults in 2020. J Psychoactive Drugs. 2023;55:445–55.
Meyer I. Minority stress and mental health in gay men. J Health Soc Behav. 1995;36:38–56.
Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychol Bull. 2003;129:674–97.
Buckner JD, Zvolensky MJ, Scherzer CR. Microaggressions and cannabis-related problems among Black adults: The roles of negative affect and cannabis use motives. Cogn Ther Res. 2023, 1–10.
Lanaway D, Burlew AK. The influence of distressed coping on the relationship between perceived racial discrimination and cannabis use among Black college students. J Psychoactive Drugs. 2021;53:404–12.
Davis SR, Prince MA, Swaim RC, Stanley LR. Comparing cannabis use motive item performance between American Indian and White youth. Drug Alcohol Depend. 2020;213:108086.
Montgomery L, Dixon S, Mantey DS. Racial and ethnic differences in cannabis use and cannabis use disorder: Implications for researchers. Curr Addict Rep. 2022;9:14–22.
Kerridge BT, Pickering RP, Saha TD, Ruan WJ, Chou SP, Zhang H, et al. Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States. Drug Alcohol Depend. 2017;170:82–92.
Krueger EA, Fish JN, Upchurch DM. Sexual orientation disparities in substance use: Investigating social stress mechanisms in a national sample. Am J Prev Med. 2020;58:59–68.
Mauro PM, Philbin MM, Greene ER, Diaz JE, Askari MS, Martins SS. Daily cannabis use, cannabis use disorder, and any medical cannabis use among US adults: Associations within racial, ethnic, and sexual minoritized identities in a changing policy context. Prev Med Rep. 2022;28:101822.
Dyar C, Lee CM, Rhew IC, Kaysen D. Sexual minority stress and substance use: An investigation of when and under what circumstances minority stress predicts alcohol and cannabis use at the event-level. J Psychopathol Clin Sci. 2023;132:475–89.
Dyar C, Feinstein BA. Event-level contextual and motivational risk factors for cannabis use: Evidence for differing associations based on individual-level patterns of cannabis use among sexual minority women and gender diverse individuals. Psychol Sex Orientat Gend Divers. 2023.
Dyar C, Feinstein BA, Newcomb ME, Whitton SW. The association between bi+ stigma and problematic cannabis use: Testing coping motives as an underlying mechanism. J Stud Alcohol Drugs. 2022;83:126–33.
Buckner JD, Threeton EM, Morris PE, Stoneking FR. Sexual orientation and cannabis outcomes among Black Individuals: The role of cannabis use motives. Addict Behav. 2023;141:107635.
McCabe CJ, Rhew IC, Walukevich-Dienst K, Graupensperger S, Lee CM. Increased coping motives during the COVID-19 pandemic widen cannabis disparities between sexual minoritized and nonminoritized young adults: A bimonthly assessment of data preceding and spanning the pandemic. Psychol Addict Behav. 2023;37:670–80.
Mahu IT, Doucet C, O’Leary-Barrett M, Conrod PJ. Can cannabis use be prevented by targeting personality risk in schools? Twenty-four-month outcome of the adventure trial on cannabis use: a cluster-randomized controlled trial. Addict Abingdon Engl. 2015;110:1625–33.
Buckner JD, Walukevich KA, Lewis EM. Cannabis use motives on weekends versus weekdays: Direct and indirect relations with cannabis use and related problems. Addict Behav. 2019;88:56–60.
Chabrol H, Chassagne J, Bronchain J, Raynal P, Carey KB. Contribution of health motives to cannabis use among college students. Addict Res Theory. 2020;28:269–73.
Schultz NR, Bassett DT, Messina BG, Correia CJ. Differential role of cannabis use motives in predicting impairment across three measures. J Stud Alcohol Drugs. 2019;80:26–31.
Skalisky J, Wielgus MD, Aldrich JT, Mezulis AH. Motives for and impairment associated with alcohol and marijuana use among college students. Addict Behav. 2019;88:137–43.
Bravo AJ, Sotelo M, Pilatti A, Mezquita L, Read JP. Depressive symptoms, ruminative thinking, marijuana use motives, and marijuana outcomes: A multiple mediation model among college students in five countries. Drug Alcohol Depend. 2019;204:107558.
Joyce KM, Thompson K, Good KP, Tibbo PG, O’Leary ME, Perrot TS, et al. The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre-menstrual dysphoric disorder. Addiction. 2021;116:2746–58.
Moitra E, Christopher PP, Anderson BJ, Stein MD. Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults. Psychol Addict Behav J Soc Psychol Addict Behav. 2015;29:627–32.
Naegele H, Betzler F, Viohl L, Koslowski M, Ernst F, Petzold MB. Cannabis use, use motives and cannabis use disorder among Berlin college students. J Drug Issues. 2022;52:568–84.
Pearson MR, Bravo AJ, Conner BT, Parnes JE. A day in the life: A daily diary examination of marijuana motives and protective behavioral strategies among college student marijuana users. J Drug Issues. 2020;50:142–56.
Cousijn J, Kuhns L, Larsen H, Kroon E. For better or for worse? A pre–post exploration of the impact of the COVID-19 lockdown on cannabis users. Addiction. 2021;116:2104–15.
Glodosky NC, Cuttler C. Motives Matter: Cannabis use motives moderate the associations between stress and negative affect. Addict Behav. 2020;102:106188.
Bonn-Miller MO, Zvolensky MJ, Bernstein A. Marijuana use motives: Concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers. Addict Behav. 2007;32:49–62.
Patrick ME, Schulenberg JE, O’Malley PM, Maggs JL, Kloska DD, Johnston LD, et al. Age-related changes in reasons for using alcohol and marijuana from ages 18 to 30 in a national sample. Psychol Addict Behav J Soc Psychol Addict Behav. 2011;25:330–9.
Zvolensky MJ, Vujanovic AA, Bernstein A, Bonn-Miller MO, Marshall EC, Leyro TM. Marijuana use motives: A confirmatory test and evaluation among young adult marijuana users. Addict Behav. 2007;32:3122–30.
Garrison E, Gilligan C, Ladd BO, Anderson KG. Social anxiety, cannabis use motives, and social context’s impact on willingness to use cannabis. Int J Environ Res Public Health. 2021;18:4882.
Boehnke KF, Gangopadhyay S, Clauw DJ, Haffajee RL. Qualifying conditions of medical cannabis license holders in the United States. Health Aff Proj Hope. 2019;38:295–302.
Solmi M, Toffol MD, Kim JY, Choi MJ, Stubbs B, Thompson T, et al. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ. 2023;382:e072348.
Goldstein AL, Shifrin A, Katz JL, Iu LK, Kofler D. Exploring the relationship between ADHD symptoms and daily cannabis consequences in emerging adulthood: The role of cannabis motives. J Stud Alcohol Drugs. 2021;82:228–36.
Haug NA, Padula CB, Sottile JE, Vandrey R, Heinz AJ, Bonn-Miller MO. Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addict Behav. 2017;72:14–20.
Hernandez M, Levin FR. Attention-deficit hyperactivity disorder and therapeutic cannabis use motives. Psychiatr Clin North Am. 2022;45:503–14.
Leung J, Chan G, Stjepanović D, Chung JYC, Hall W, Hammond D. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada. Psychopharmacology. 2022;239:1509–19.
Baumbusch J, Sloan YI. Exploring new use of cannabis among older adults. Clin Gerontol J Aging Ment Health. 2021;44:25–31.
Clem SN, Bigand TL, Wilson M. Cannabis Use Motivations among Adults Prescribed Opioids for Pain versus Opioid Addiction. Pain Manag Nurs. 2020;21:43–7.
Kvamme SL, Pedersen MM, Rømer Thomsen K, Thylstrup B. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduct J. 2021;18:72.
Manning L, Bouchard L. Medical cannabis use: Exploring the perceptions and experiences of older adults with chronic conditions. Clin Gerontol J Aging Ment Health. 2021;44:32–41.
Morean ME, Lederman IR. Prevalence and correlates of medical cannabis patients’ use of cannabis for recreational purposes. Addict Behav. 2019;93:233–9.
Potts JM, Getachew B, Vu M, Nehl E, Yeager KA, Berg CJ. Use and Perceptions of Opioids versus Marijuana among People Living with HIV. Am J Health Behav. 2020;44:807–19.
Edwards D, Filbey FM. Are sweet dreams made of these? Understanding the relationship between sleep and cannabis use. Cannabis Cannabinoid Res. 2021;6:462–73.
Walsh Z, Gonzalez R, Crosby K, S. Thiessen M, Carroll C, Bonn-Miller MO. Medical cannabis and mental health: A guided systematic review. Clin Psychol Rev. 2017;51:15–29.
Coelho SG, Hendershot CS, Rueda S, Wardell JD. Daily associations between cannabis use and alcohol use among people who use cannabis for both medicinal and nonmedicinal reasons: Substitution or complementarity? Psychol Addict Behav. 2023;37:1006–18.
Karoly HC, Schacht JP, Meredith LR, Jacobus J, Tapert SF, Gray KM, et al. Investigating a novel fMRI cannabis cue reactivity task in youth. Addict Behav. 2019;89:20–8.
Wall MM, Liu J, Hasin DS, Blanco C, Olfson M. Use of marijuana exclusively for medical purposes. Drug Alcohol Depend. 2019;195:13–5.
Wardell JD, Rueda S, Elton-Marshall T, Mann RE, Hamilton HA. Prevalence and correlates of medicinal cannabis use among adolescents. J Adolesc Health. 2021;68:103–9.
Kurtzman ET, Young-Wolff KC. Why do Americans use marijuana? Drug Alcohol Depend. 2021;226:108880.
Chabrol H, Beck C, Laconi S. Contribution of health motive to cannabis use among high-school students. Addict Behav. 2017;64:54–6.
Fales JL, Ladd BO, Magnan RE. Pain Relief as a Motivation for cannabis use among young adult users with and without chronic pain. J Pain. 2019;20:908–16.
Dawson D, Stjepanović D, Lorenzetti V, Cheung C, Hall W, Leung J. The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis. Drug Alcohol Depend. 2024;257:111263.
Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse. 2014;40:23–30.
Wallis D, Coatsworth JD, Mennis J, Riggs NR, Zaharakis N, Russell MA, et al. Predicting self-medication with cannabis in young adults with hazardous cannabis use. Int J Environ Res Public Health. 2022;19:1850.
Dowd AN, Zamarripa CA, Sholler DJ, Strickland JC, Goffi E, Borodovsky JT, et al. A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products. Drug Alcohol Depend. 2023;245:109826.
Lankenau SE, Fedorova EV, Reed M, Schrager SM, Iverson E, Wong CF. Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug Alcohol Depend. 2017;170:181–8.
Spinella TC, Bartholomeusz J, Stewart SH, Barrett SP. Perceptions about THC and CBD effects among adults with and without prior cannabis experience. Addict Behav. 2023;137:107508.
Substance Abuse and Mental Health Services Administration. White paper on screening, brief intervention and referral to treatment (SBIRT) in behavioral healthcare - 2011. 2011. Available online at https://www.samhsa.gov/sbirt/resources.
Kepner WE, Han BH, Nguyen D, Han SS, Lopez FA, Palamar JJ. Past-month binge drinking and cannabis use among middle-aged and older adults in the United States, 2015–2019. Alcohol. 2023;107:32–7.
Funding
Open access funding provided by the Carolinas Consortium. This work was supported by the National Institutes of Health [grant numbers T32 DA007288 and K12 DA031794, awarded to Kathryn Gex].
Author information
Authors and Affiliations
Contributions
KSG conducted the literature searches. KSG, TG, and JW wrote the initial draft of the manuscript. The drafts were substantially revised by all authors. TG prepared the table. All authors contributed to, reviewed, and have approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gex, K.S., Gückel, T., Wilson, J. et al. Why People Use Cannabis and Why It Matters: A Narrative Review. Curr Addict Rep (2024). https://doi.org/10.1007/s40429-024-00599-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s40429-024-00599-3